Per aspirin ad astra...

ATLA Alternatives to Laboratory Animals

Volumn 37, Issue SUPPL. 2, 2009, Pages 45-47

  Hartung, Thomas ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Alternatives; Animal testing; Aspirin toxicology; REACH; Toxicology limitations

Indexed keywords

ACETYLSALICYLIC ACID; PARACETAMOL;

ANIMAL TESTING ALTERNATIVE; DRUG SAFETY; ETHICS; EXPERIMENTAL ANIMAL; HEALTH PROGRAM; PRIORITY JOURNAL; REVIEW; TOXICOLOGY;

ANIMALIA;

EID: 77749314440     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290903702s10     Document Type: Review

References (25)

1. Hartung, T. (2008). Towards a new toxicology - evolution or revolution? ATLA 36, 635-639.
2. Anon. (last revised 2008). Material Safety Data Sheet: Acetylsalicylic Acid, 7pp. Fair Lawn NJ, USA: Acros Organics N.V. Available at: http://www.westliberty.edu/uploadedFiles/Office/Safety-and-Health/MSDS-pdfs/ Acetylsalicylic%20Acid.pdf (Accessed 04.09.09).
3. Gold, L.S. (2009). The Carcinogenic Potency Project: Aspirin. Available at: http://potency.berkeley.edu/chempages/ASPIRIN.html (Accessed May 2009).
4. Giri, A.K. (1993). The genetic toxicology of paracetamol and aspirin: a review. Mutation Research 296, 199-210.
5. Joschko, M.A., Dreosti, I.E. & Tulsi, R.S. (1993). The teratogenic effects of salicylic acid on the developing nervous system in rats in vitro. Teratology 48, 105-114.
6. Barrow, P.C. (2002). Preclinical testing for teratogenicity and developmental toxicity: methods and limitations. Therapie 57, 109-114.
7. Cappon, G.D., Gupta, U., Cook, J.C., Tassinari, M.S. & Hurtt, M.E. (2003). Comparison of the developmental toxicity of aspirin in rabbits when administered throughout organogenesis or during sensitive windows of development. Birth Defects Research. B. Developmental Reproductive Toxicology 68, 38-46.
8. Cook, J.C., Jacobson, C.F., Gao, F., Tassinari, M.S., Hurtt, M.E. & DeSesso, J.M. (2003). Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits. Birth Defects Research. B. Developmental Reproductive Toxicology 68, 5-26.
9. Gupta, U., Cook, J.C., Tassinari, M.S. & Hurtt, M.E. (2003). Comparison of developmental toxicology of aspirin (acetylsalicylic acid) in rats using selected dosing paradigms. Birth Defects Research. B. Developmental Reproductive Toxicology 68, 27-37.
10. Harris, G. (1996). Aspirin sales rise in adult analgesic category despite increased competition; life-saving benefits of the time-tested pain reliever attract new users. Business Wire, Jan 17, 1996. Available at: http://findarticles.com/p/articles/mi-m0EIN/is-1996-Jan-17/ai-17830407/ (Accessed 04.09.09).
11. Arthur, C. (2003). Analysis Aspirin: One million billion doses taken and still counting... The Independent (London), 6 March 2003. Available at: http://findarticles.eom/p/articles/mi-qn4158/is-20030306/ai-n12673463/ (Accessed 04.09.09).
12. Jeffreys, D. (2004). Aspirin: The remarkable story of a wonder drug, 323pp. New York, NY, USA: Bloomsbury.
13. Bayer AG (2007). Still in the Spotlight after 110 Years: Aspirin® - The Evergreen of the Pharmacy. [Press release, 8 March 2007]. Berlin, Germany: Bayer AG. Available at: http://www.viva.vita.bayerhealthcare.com/index. php?id=36&no-cache=1&tx-ttnews%5Btt-news%5D=11968 (Accessed 04.09.09).
14. Kozer, E., Nikfar, S., Costei, A., Boskovic, R., Nulman, I. & Koren, G. (2002). Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. American Journal of Obstetrics & Gynecology 187, 1623-1630.
15. Hartung, T. (2008). Food for thought... on animal tests. ALTEX 25, 3-9.
16. Bottini, A.A., & Hartung, T. (2009). Food for thought... on economics of animal testing. ALTEX 26, 3-16.
17. Hartung, T. (2009). Toxicology for the twenty-first century. Nature, London 460, 208-212.
18. European Commission (2006). Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Official Journal of the European Union L396/1 (30.12.2006), 1-849. Available at: http://eurlex.europa.eu/LexUriServ/ LexUriServ.do?uri=oj:l:2006:396:0001:0849:en:pdf (Accessed 04.09.09).
19. Hoffmann, S., Edler, L., Gardner, I., Gribaldo, L., Hartung, T., Klein, C., Liebsch, M., Sauerland, S., Schechtman, L., Stammati, A. & Nikolaidis, E. (2008). Points of reference in validation. The report and recommendations of ECVAM Workshop 66. ATLA 36, 343-352.
20. Hartung, T. & Leist, M. (2008). Food for thought... on the evolution of toxicology and phasing out of animal testing. ALTEX 25, 91-96.
21. Leist, M., Hartung, T. & Nicotera, P. (2008). The dawning of a new age of toxicology. ALTEX 25, 103-114.
22. Hartung, T. (2008). Food for thought... on alternative methods for cosmetics safety testing. ALTEX 25, 147-162.
23. Hartung, T. (2009). A toxicology for the 21st century: Mapping the road ahead. Toxicological Sciences 109, 18-23.
24. Hoffmann, S. & Hartung, T. (2006). Towards an evidence-based toxicology. Human & Experimental Toxicology 25, 497-513.
25. Various authors (2009). Proceedings of the First International Forum Towards Evidence-based Toxicology, Como, Italy (2007). Human & Experimental Toxicology, Special Issue: Evidence-based Toxicology (EBT), 28, 71-163.